Reversible cyclosporine-induced cortical blindness in allogeneic bone marrow transplant recipients.

Bone Marrow Transplant

Division of Hematology/Bone Marrow Transplantation, Pittsburgh Cancer Institute, University of Pittsburgh Medical Center, PA 15213-2582, USA.

Published: February 1995

We report the occurrence of reversible cyclosporine-induced cortical blindness in three allogeneic bone marrow transplant recipients. Possible mechanisms involved in this rare complication, as well as the associated radiographic and pathologic findings, are discussed.

Download full-text PDF

Source

Publication Analysis

Top Keywords

reversible cyclosporine-induced
8
cyclosporine-induced cortical
8
cortical blindness
8
allogeneic bone
8
bone marrow
8
marrow transplant
8
transplant recipients
8
blindness allogeneic
4
recipients report
4
report occurrence
4

Similar Publications

Article Synopsis
  • A 29-year-old Korean woman with chronic aplastic anemia experienced seizures linked to complications from cyclosporine treatment.
  • The condition was identified as posterior reversible encephalopathy syndrome due to unpredictable accumulation of the drug.
  • This case highlights the importance of closely monitoring cyclosporine levels and making careful dose adjustments to avoid complications.
View Article and Find Full Text PDF

Oxidative stress and aberrant inflammatory response have important implications in cyclosporin-induced reproductive functions. Previous studies have shown that agents with antioxidant and anti-inflammatory activities might be beneficial in reversing cyclosporin-induced reproductive impairment. Lutein is a naturally occurring compound with antioxidant and anti-inflammatory properties.

View Article and Find Full Text PDF

Erythromelalgia is a rare syndrome characterised by recurrent erythema, heat and burning pain in the extremities. There are two types: primary (genetic) and secondary (toxic, drug-related or associated with other diseases). We report a 42-year-old woman who developed erythromelalgia after taking cyclosporine for myasthenia gravis.

View Article and Find Full Text PDF

Cyclosporine-Induced Posterior Reversible Encephalopathy Syndrome: An Adverse Effect in a Patient With Atopic Dermatitis.

Cutis

March 2023

Dr. C.P. Dunn is from the Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle. Dr. C.L. Dunn is from the Department of Dermatology, KCU-GME/ADCS Consortium, Maitland, Florida. Dr. Petroni is from the Northwest Allergy and Asthma Center, University of Washington, Seattle.

View Article and Find Full Text PDF

Cyclosporine (CsA) is considered one of the main components of treatment protocols for organ transplantation owing to its immunosuppressive effect. However, its use is very restricted due to its nephrotoxic effect. ZW is an alkaline fluid rich in various trace elements and has a great ability to stimulate antioxidant processes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!